Bluejay Diagnostics, Inc.
Income Statement
| Line Item | FY2022 |
|---|---|
| Revenue | $249.0K |
| Cost of Revenue | $200.1K |
| Gross Profit | $48.9K |
| Gross Margin | 19.6% |
| Operating Expenses | |
| Research & Development | $4.2M |
| SG&A Expense | $451.4K |
| Operating Income | $-9.3M |
| Operating Margin | -3,741.5% |
| Interest Expense | — |
| Pretax Income | — |
| Income Tax Expense | — |
| Net Income | $-9.3M |
| Net Margin | -3,733.1% |
| EPS (Basic) | $-0.92 |
| EPS (Diluted) | $-0.92 |
| Shares Outstanding (Basic) | 10.1M |
| Shares Outstanding (Diluted) | 10.1M |
| Dividends Per Share | — |